These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2872929)

  • 41. The effect of fibrin polymers on thrombin-catalyzed plasma factor XIIIa formation.
    Greenberg CS; Miraglia CC
    Blood; 1985 Aug; 66(2):466-9. PubMed ID: 2861869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of formation of factor XIIIa by its fibrin substrates.
    Lewis SD; Janus TJ; Lorand L; Shafer JA
    Biochemistry; 1985 Nov; 24(24):6772-7. PubMed ID: 2866798
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fibronectin and fibrin gel structure.
    Okada M; Blombäck B; Chang MD; Horowitz B
    J Biol Chem; 1985 Feb; 260(3):1811-20. PubMed ID: 2857179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals.
    Pisano JJ; Bronzert TJ; Peyton MP; Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():98-113. PubMed ID: 4629559
    [No Abstract]   [Full Text] [Related]  

  • 45. Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII).
    Gorman JJ; Folk JE
    J Biol Chem; 1980 Jan; 255(2):419-27. PubMed ID: 6101325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A monoclonal antibody against a peptide sequence of fibrinogen gamma chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin.
    Taubenfeld SM; Song Y; Sheng D; Ball EL; Matsueda GR
    Thromb Haemost; 1995 Sep; 74(3):923-7. PubMed ID: 8571322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Importance of plasma fibronectin in determining PFP and PRP clot mechanical properties.
    Chow TW; McIntire LV; Peterson DM
    Thromb Res; 1983 Jan; 29(2):243-8. PubMed ID: 6845279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast migration in fibrin gel matrices.
    Brown LF; Lanir N; McDonagh J; Tognazzi K; Dvorak AM; Dvorak HF
    Am J Pathol; 1993 Jan; 142(1):273-83. PubMed ID: 8424460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytofluorometric identification of plasmin-sensitive factor XIIIa binding to platelets.
    Kreager JA; Devine DV; Greenberg CS
    Thromb Haemost; 1988 Aug; 60(1):88-93. PubMed ID: 2903577
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard.
    Puszkin EG; Raghuraman V
    J Biol Chem; 1985 Dec; 260(29):16012-20. PubMed ID: 2866189
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
    Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
    J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human fibrinogen free of factor XIII: the pursuit of biological zero.
    Finlayson JS
    Ann N Y Acad Sci; 1972 Dec; 202():149-54. PubMed ID: 4629549
    [No Abstract]   [Full Text] [Related]  

  • 56. Factor XIIIa cross-linking of the Marburg fibrin: formation of alpham.gamman-heteromultimers and the alpha-chain-linked albumin. gamma complex, and disturbed protofibril assembly resulting in acquisition of plasmin resistance relevant to thrombophila.
    Sugo T; Nakamikawa C; Takebe M; Kohno I; Egbring R; Matsuda M
    Blood; 1998 May; 91(9):3282-8. PubMed ID: 9558384
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacologic evaluation of factor XIIIa*-like enzyme activity in equine plasma as a potential therapeutic avenue for the inhibition of fibrinous tissue.
    Coyne CP; Smith JE; DeBowes RM
    Am J Vet Res; 1992 May; 53(5):695-705. PubMed ID: 1355954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial-derived von Willebrand factor accelerates fibrin clotting within engineered microvessels.
    Rayner SG; Scholl Z; Mandrycky CJ; Chen J; LaValley KN; Leary PJ; Altemeier WA; Liles WC; Chung DW; López JA; Fu H; Zheng Y
    J Thromb Haemost; 2022 Jul; 20(7):1627-1637. PubMed ID: 35343037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.
    Parameswaran KN; Velasco PT; Wilson J; Lorand L
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8472-5. PubMed ID: 1978326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.